BGHL (EUR): NAV(s)                          

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
718
BGHL (EUR): NAV(s)

                                       BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares

The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.

 

Close of business 06 Jun 2018.

 

Estimated NAV

 

  Euro Shares Sterling Shares
Estimated NAV €  23.7375 £  21.0401
Estimated MTD return  0.37 %  0.38 %
Estimated YTD return  1.24 %  1.60 %
Estimated ITD return  137.38 %  110.40 %

 

NAV and returns are calculated net of management and performance fees

 

Market information

 

Euro Shares Amsterdam (AEX) London (LSE)
Market Close €  19.70 N/A
Premium/discount to estimated NAV  -17.01 % N/A
     
Sterling Shares Amsterdam (AEX) London (LSE)
Market Close N/A GBX 1,735.00
Premium/discount to estimated NAV N/A  -17.54 %

 

 

Transactions in own securities purchased into treasury

 

Ordinary Shares Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A
Range of Price N/A N/A

           

                                           

Liquidity Enhancement Agreement Euro Shares Sterling Shares
Number of shares N/A N/A
Average Price N/A N/A

 

BGHL Capital

 

BGHL Ordinary Shares Euro Shares Sterling Shares
Shares Outstanding  28,758,219  632,590
Held in treasury N/A N/A
Shares Issued  28,758,219  632,590

 

Estimated BG Fund NAV

Class B Euro Shares (estimated) €  190.8265

 

The Class B Euro Shares of BG Fund are not subject to investment manager fees, as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.

 

For further information please contact:

Boussard & Gavaudan Investment Management, LLP. Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.com

 

The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the "Shares") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.

This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute, or form part of, any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.

Neither the Company nor BG Fund ICAV has been, and neither will be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"). Consequently any such securities may not be offered, sold or otherwise transferred within the United States or to, or for the account or benefit of, US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.

You should always bear in mind that:

all investment is subject to risk;

results in the past are no guarantee of future results;

the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; and

if you are in any doubt about the contents of this communication or if you consider making an investment decision, you are advised to seek expert financial advice.

 

This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.

 

 

 

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 12

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

ASP Isotopes Inc. Investors Urged to Join Class Action Lawsuit

Updated Category News Views 135

Class Action Lawsuit Announced for ASP Isotopes Investors ASP Isotopes Inc. has recently found itself in the midst of a class action lawsuit that many investors might want to pay attention to. This lawsuit has been initiated by Bronstein, Gewirtz & Grossman, LLC, a well-regarded law firm specializing in securities fraud. Investors whose financial interests have suffered...

Continue Reading
Boeing and Korean Air Announce Historic $36 Billion Purchase

Updated Category News Views 136

Boeing Secures Major Deal with Korean Air Boeing Co. (NASDAQ: BA) has entered into a remarkable $36.2 billion agreement with Korean Air. This historic deal encompasses the purchase of 103 aircraft, a strategic move coinciding with efforts to bolster American business interests internationally. Details of the Agreement and Fleet Modernization Announced recently, this...

Continue Reading
Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 20

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
European Stocks Surge Amid Easing Middle East Tensions

Updated Category News Views 67

European Markets Rally on Positive Sentiment European stock markets experienced a modest rise recently, primarily driven by the easing geopolitical tensions in the Middle East. This optimism comes at a crucial time as investors prepare for a week filled with potential market influences. As of early trading, Germany's DAX index climbed by 0.3%, while France's CAC 40 saw an...

Continue Reading
XPeng's Middle East Plans and the EV Landscape Ahead

Updated Category News Views 185

A Week of Mixed Developments in the EV and Travel Sectors This week marked a significant moment in the tech and travel sectors, showcasing both opportunities and challenges. Chinese electric vehicle (EV) manufacturer XPeng Inc. has announced its ambitious expansion plans aimed at the Middle East and Africa. This strategic move aligns with China's broader goals of...

Continue Reading